Clinical Trials Directory

Trials / Unknown

UnknownNCT03351673

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
45 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTendometrial volume 2D TVScalculation the endometrial volume using 2D ultrasound and correlation the results with the pathological findings of endometrial biopsy

Timeline

Start date
2017-08-08
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2017-11-24
Last updated
2017-11-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03351673. Inclusion in this directory is not an endorsement.